| Maria M Ariton, MD | |
|
11 Ralph Pl, Staten Island, NY 10304-4419 | |
| (718) 273-8191 | |
| (718) 816-1467 |
| Full Name | Maria M Ariton |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 11 Ralph Pl, Staten Island, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750341145 | NPI | - | NPPES |
| 00952896 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 159082 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria M Ariton, MD 11 Ralph Pl, Staten Island, NY 10304-4419 Ph: (718) 273-8191 | Maria M Ariton, MD 11 Ralph Pl, Staten Island, NY 10304-4419 Ph: (718) 273-8191 |
News Archive
The CAREPATH project launched on 1st of July 2021, is a European Horizon 2020's project that proposes an ICT based solution for the optimization of clinical practice in the treatment and management of multimorbid patients with Mild Cognitive Impairment (MCI) or mild dementia (MD).
Coalition to Protect Patients' Rights (CPPR) spokesman, Dr. Donald J. Palmisano, today said that a federal judge's ruling on the unconstitutionality of the Affordable Care Act's individual mandate could lead to new, patient-focused reforms to the American health care system.
A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the U.S. population and costs billions in Medicare spending each year.
Oncothyreon Inc. (NASDAQ: ONTY) (TSX: ONY) today reported a net loss of $6.3 million, or $0.30 per basic and diluted share, for the three months ended June 30, 2009, compared with a net loss of $4.9 million, or $0.25 per basic and diluted share, for the comparable period in 2008.
A new review of studies confirms that the drug metformin should be in the first line of defense against type 2 diabetes.
› Verified 1 days ago
Liliane Sarkis Deeb, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4106 Hylan Blvd, Staten Island, NY 10308 Phone: 718-226-7855 Fax: 718-227-5814 | |
Deepak Vadada, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1050 Clove Rd, Staten Island, NY 10301 Phone: 718-816-6440 Fax: 718-816-3611 | |
Dr. Samantha Maria Lee, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-9510 Fax: 718-226-3473 | |
Dr. Jean Chalhoub, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Avenue, Department Of Internal Medicine, Staten Island, NY 10305 Phone: 718-226-8855 | |
Dr. Gustave Stephen Drivas, M.D., Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 5405 Hylan Blvd, Staten Island, NY 10312 Phone: 718-948-3890 Fax: 718-948-3961 | |
Dr. Beatrice Nogueira, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-6902 Fax: 718-226-6844 | |
Dr. Felicia Tenedios, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1200 South Ave Ste 204, Staten Island, NY 10314 Phone: 718-447-0055 Fax: 718-876-5212 |